Amalgamated Bank Sells 640 Shares of Chemed Co. (NYSE:CHE)

Amalgamated Bank cut its stake in shares of Chemed Co. (NYSE:CHE) by 7.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,676 shares of the company’s stock after selling 640 shares during the period. Amalgamated Bank owned about 0.05% of Chemed worth $4,165,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. EntryPoint Capital LLC lifted its stake in Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after acquiring an additional 18 shares in the last quarter. Covestor Ltd lifted its stake in Chemed by 10.6% during the 1st quarter. Covestor Ltd now owns 219 shares of the company’s stock valued at $141,000 after acquiring an additional 21 shares in the last quarter. Ballentine Partners LLC raised its stake in shares of Chemed by 3.4% during the 1st quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock worth $424,000 after purchasing an additional 22 shares during the period. GAMMA Investing LLC raised its stake in shares of Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after purchasing an additional 22 shares during the period. Finally, Waterloo Capital L.P. raised its stake in shares of Chemed by 1.1% during the 4th quarter. Waterloo Capital L.P. now owns 2,252 shares of the company’s stock worth $1,317,000 after purchasing an additional 25 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Chemed Price Performance

NYSE CHE opened at $582.06 on Friday. The stock has a market capitalization of $8.81 billion, a price-to-earnings ratio of 31.33, a PEG ratio of 2.31 and a beta of 0.44. Chemed Co. has a one year low of $497.36 and a one year high of $654.62. The business’s fifty day moving average is $569.34 and its 200-day moving average is $577.64.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The business had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.71 earnings per share. Research analysts expect that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. This is a boost from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. Chemed’s payout ratio is presently 10.76%.

Insider Buying and Selling

In related news, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the completion of the sale, the chief executive officer now owns 105,735 shares of the company’s stock, valued at approximately $60,229,828.05. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,744 shares of company stock valued at $3,828,231. 3.32% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.